SERMONIX NEW LOGO JPEG (2).jpg
Sermonix Surveys Find Vaginal/Sexual Health Symptoms Are Among Most Significant Issues Affecting Lives of ER+/HER2- Metastatic Breast Cancer Patients
November 02, 2024 09:00 ET | Sermonix Pharmaceuticals Inc.
COLUMBUS, Ohio, Nov. 02, 2024 (GLOBE NEWSWIRE) -- Sermonix Pharmaceuticals Inc., a privately held biopharmaceutical company developing innovative therapeutics to specifically treat metastatic breast...
SERMONIX NEW LOGO JPEG (2).jpg
Sermonix Pharmaceuticals to Host Oral Presentation on Vaginal and Sexual Health at RISE UP for Breast Cancer Conference
October 21, 2024 09:00 ET | Sermonix Pharmaceuticals Inc.
COLUMBUS, Ohio, Oct. 21, 2024 (GLOBE NEWSWIRE) -- Sermonix Pharmaceuticals Inc., a privately held biopharmaceutical company developing innovative therapeutics to specifically treat metastatic breast...
SERMONIX NEW LOGO JPEG (2).jpg
Sermonix Pharmaceuticals Announces ‘Menopause’ Journal Publication of Article on Oral Lasofoxifene’s Effects on Vaginal Atrophy in Postmenopausal Women
April 29, 2024 09:00 ET | Sermonix Pharmaceuticals Inc.
COLUMBUS, Ohio, April 29, 2024 (GLOBE NEWSWIRE) -- Sermonix Pharmaceuticals Inc., a privately held biopharmaceutical company developing innovative therapeutics to specifically treat metastatic...
SERMONIX NEW LOGO JPEG (2).jpg
Sermonix Pharmaceuticals Shares Results of Third Survey on ESR1 and Metastatic Breast Cancer Patient Quality of Life
December 12, 2023 09:00 ET | Sermonix Pharmaceuticals Inc.
Most patients minimized or hid side effects from their health care providers for fear of negative perceptions, reduced treatment efficacy, or being taken off a drug or out of a clinical trialSexual...
SERMONIX NEW LOGO JPEG (2).jpg
Sermonix to Present Poster Comparing Lasofoxifene and Fulvestrant Effect on Vaginal Health at International Society for the Study of Women's Sexual Health Annual Meeting 2023
February 08, 2023 09:00 ET | Sermonix Pharmaceuticals Inc.
COLUMBUS, Ohio, Feb. 08, 2023 (GLOBE NEWSWIRE) -- Sermonix Pharmaceuticals Inc., a privately held biopharmaceutical company developing innovative therapeutics to specifically treat metastatic breast...
Life Extension new FLORASSIST® Probiotic Women's Health dietary supplement for vaginal, digestive and immune support non-GMO gluten-free vegetarian
New FLORASSIST® Probiotic Women’s Health Supports Vaginal, Digestive and Immune Health
August 18, 2022 10:15 ET | Life Extension
Fort Lauderdale, FL, Aug. 18, 2022 (GLOBE NEWSWIRE) -- Women’s probiotics designed to promote a healthy vaginal pH balance are increasingly popular in today’s supplement marketplace—but most...
Applicator & Gel EN
Keeping Your Vagina Clean, Comfortable, and Happy, with the Newly Designed Patented Smooth Applicator
June 26, 2018 09:00 ET | Aurium Pharma Inc.
TORONTO, June 26, 2018 (GLOBE NEWSWIRE) -- Not everyone has symptoms when they’ve contracted vaginal infections, roughly 1 in 3 women contract bacterial vaginosis but many are unaware they have it....